Baltrus Victoria sold $24K of OSCR
Baltrus Victoria (Chief Accounting Officer) sold 1,091 shares of Oscar Health, Inc. (OSCR) at $21.74 on 2026-06-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Because the trade is explicitly under a pre-arranged 10b5-1 plan, it generally carries less informational content than unscheduled selling.
Market read
Traders may note the insider sale for sentiment monitoring, but there is no new fundamental catalyst in the filing.
What to watch
The sale size is relatively small versus typical institutional float; also, 10b5-1 trades are scheduled and not necessarily predictive of near-term performance.
Background
The article is a SEC Form 4 insider transaction disclosure (officer open-market sale) for Oscar Health.
Ticker impact
Oscar Health disclosed an officer open-market sale of 1,091 shares at $21.74 on a pre-arranged 10b5-1 plan.
Likely limited/short-lived impact; any reaction is more sentiment-driven than fundamental.
The filing is a routine Form 4 with a stated pre-arranged 10b5-1 plan and no accompanying company-specific operational or financial change.
Market effects
Minimal; this is company-specific insider activity without sector-wide catalyst.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated selling by insiders can coincide with perceived valuation risk or liquidity needs, which can still pressure sentiment.
Key entities
- issuerOscar Health, Inc.
Subject of the Form 4 insider transaction; officer Baltrus Victoria sold shares under a 10b5-1 plan.
- insiderBaltrus Victoria
Chief Accounting Officer who executed the reported open-market sale.
